Stereotaxis/STXS

$2.67

-1.48%
-
1D1W1MYTD1YMAX

About Stereotaxis

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Ticker

STXS

Sector

Healthcare

Trading on

AMEX

Industry

Medical Equipment & Supplies

CEO

David Fischel

Employees

122

Headquarters

St. louis, United States

Stereotaxis Metrics

BasicAdvanced
$222.57M
Market cap
-
P/E ratio
-$0.27
EPS
1.31
Beta
-
Dividend rate
$222.57M
1.30574
$3.29
$1.33
307.9K
2.511
1.875
-43.46%
-103.35%
-61.11%
8.314
13.422
10.154
-4.89%
-6.04%
0.18%

What the Analysts think about Stereotaxis

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 5 analysts.
72.28% upside
High $5.00
Low $4.00
$2.67
Current price
$4.60
Average price target

Stereotaxis Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-111.11% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$4.5M
-41.56%
Net income
$-5M
-5.66%
Profit margin
-111.11%
61.43%

Stereotaxis Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 6.06%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.07
-$0.07
-$0.07
-$0.07
-
Expected
-$0.06
-$0.07
-$0.06
-$0.07
-$0.06
Surprise
21.21%
-3.05%
15.51%
6.06%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Stereotaxis stock?

Stereotaxis (STXS) has a market cap of $222.57M as of April 15, 2024.

What is the P/E ratio for Stereotaxis stock?

The price to earnings (P/E) ratio for Stereotaxis (STXS) stock is 0 as of April 15, 2024.

Does Stereotaxis stock pay dividends?

No, Stereotaxis (STXS) stock does not pay dividends to its shareholders as of April 15, 2024.

When is the next Stereotaxis dividend payment date?

Stereotaxis (STXS) stock does not pay dividends to its shareholders.

What is the beta indicator for Stereotaxis?

Stereotaxis (STXS) has a beta rating of 1.31. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Stereotaxis stock price target?

The target price for Stereotaxis (STXS) stock is $4.6, which is 72.28% above the current price of $2.67. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Stereotaxis stock

Buy or sell Stereotaxis stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing